Global Genotyping Market Insights Forecasts to 2033

• The Global Genotyping Market Size was Valued at USD 20.42 Billion in 2023
• The Market Size is Growing at a CAGR of 15.09% from 2023 to 2033
• The Worldwide Genotyping Market Size is Expected to Reach USD 83.26 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

 

Get more details on this report -

Request Free Sample PDF

 

The Global Genotyping Market Size is Anticipated to Exceed USD 83.26 Billion by 2033, Growing at a CAGR of 15.09% from 2023 to 2033.

 

Market Overview

Genotyping is an investigational process that identifies the differences in DNA sequence among individuals or groups. It is used to recognize the link between genotype (the primary genetic code) and phenotype (the visible organismal structure). An independent genome is identified as a definite variant when compared to the standard sequence, which is derived from the general group or defined subgroup. There are various types of genetic variations that involve single nucleotide variants (SNV), single nucleotide polymorphisms (SNPs), insertions and deletions (indels), translocations, and copy number variation (CNV). Different key techniques are used in genotyping, such as genome-wide genotyping, SNP and SNV genotyping, custom genotyping, targeted genotyping, copy number variation analysis, and high-throughput genotyping. Genomic-based techniques like genotyping are essential tools in the healthcare sector to facilitate fast sequencing and early diagnosis of diseases like cancer, diabetes, and Alzheimer's. Healthcare workers progressively depend on this technique for making knowledgeable decisions regarding potential treatment options, which eventually impacts market dynamics and positivity. The occurrence of high-throughput genotyping techniques has remarkably boosted the speed and accuracy of genetic testing, thereby promoting increased adoption in various research and clinical applications. Additionally, the rising scope of precision medicine and the increasing significance of genomics in disease diagnostics and treatment preparation are critical drivers of market growth.

 

Report Coverage

This research report categorizes the market for the global genotyping market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global genotyping market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global genotyping market.

 

Driving Factors

The increasing prevalence of different target diseases, like cancer, diabetes, and Alzheimer's, is the main factor raising the growth and demand of the genotyping market. In drug development for genetic disorders and rare diseases, genotyping is widely used. Increasing funding for research and development, especially in advanced countries, about medical drugs and devices will boost market growth opportunities. Surging the centre towards improving healthcare facility ambience and overall healthcare facilities is another key factor driving market growth. The increasing number of partnerships and planned collaborations between the public and private players regarding expenditure and application of new and advanced technology is further driving the growth of the genotyping market.

 

Restraining Factors

The high cost of genotyping is predicted to restrain market growth. Genotyping equipment has advanced technology, so it is expensive. The fitting and maintenance costs of this equipment are significantly high. The strict rules and regulations and unfavourable refund policies affect the overall growth of the market. One significant restraint in the global genotyping market is the ethical and privacy issues regarding genetic testing. The approach to an individual’s genetic information increases the issues related to misuse or misinterpretation of such data. These factors restrict the growth of the global genotyping market.

 

Market Segmentation

The global genotyping market share is classified into product, technology, and application.

• The reagent & kit segment is anticipated to hold the largest share of the global genotyping market over the predicted time period.

On the basis of product, the global genotyping market is divided into reagent & kit, instrument, software, and service. Among these, the reagent & kit segment is anticipated to hold the largest share of the global genotyping market over the predicted time period. The reagent & kit has experienced a surge in demand because of their inherent role in making accurate and high-throughput genotyping procedures. Laboratories, research institutes, and biotechnology industries growth depends on specific reagents and kits for their genotyping attempts, therefore boosting the growth of the genotyping market. In addition, innovative technology and a rush in genomic research activities have further propelled the demand for reagent & kit.

 

• The PCR segment is anticipated to grow at the fastest rate in the global genotyping market over the predicted time period.

On the basis of technology, the global genotyping market is divided into PCR, sequencing, microarray, and mass spectroscopy. Among these, the PCR segment is anticipated to grow at the fastest rate in the global genotyping market over the predicted time period. The universal adoption of PCR can be attributed to its high efficiency in amplifying DNA segments with high accuracy and speed, making it a crucial tool for genotyping applications. Genotyping permits researchers to investigate large structural variations in DNA and small genetic changes in DNA, such as single nucleotide polymorphisms (SNPs). The rising demand for advanced diagnostic techniques, the increasing number of CROs and forensic and research laboratories, and the rising prevalence of diseases involving chronic diseases and genetic disorders are key factors anticipated to grow the market for this segment.

 

• The diagnostics & personalized medicine segment is anticipated to hold the largest share of the global genotyping market over the predicted time period.   

On the basis of application, the global genotyping market is divided into diagnostics & personalized medicine, pharmacogenomics, and animal genetics. Among these, the diagnostics & personalized medicine segment is anticipated to hold the largest share of the global genotyping market over the predicted time period. The growing adoption of genotyping products for research and the rising demand for the diagnosis of genetic disease. Additionally, deliberate collaboration among key players is predicted to drive market growth. The diagnostic abilities of genotyping have significantly boosted its applications, permitting healthcare professionals to detect genetic markers related to various diseases, allowing early detection, prognosis, and personalized treatment plans. Furthermore, the rising demand for accurate drugs has driven the combination of genotyping into drug development procedures, making possible the design of targeted therapies based on patients genetic profiles.

 

Regional Segment Analysis of the Global Genotyping Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the greatest share of the global genotyping market over the predicted timeframe.

 

Get more details on this report -

Request Free Sample PDF

 

North America is anticipated to hold the greatest share of the global genotyping market over the predicted timeframe. This region has well-developed healthcare facilities and a high adoption rate of genotyping procedures. North America is a hub for many lead genotyping companies, research institutes, and academic centres, which provide its authority in the market. The growing adoption of innovative products, the presence of key pharmaceutical and biopharmaceutical companies, dynamic government measures, and advances in healthcare facilities. The strong focus of the region on genetic research, personalized medicine, and accurate healthcare drives the need for the genotyping market during the forecast period.

 

Asia-Pacific is anticipated to grow at the fastest rate in the global genotyping market over the predicted timeframe. The presence of huge undeveloped opportunities and the rising number of clinical trials being conducted in this region. This growth can also be attributed to other factors, like advanced technology and the rising pharmaceutical and biopharmaceutical industries in this region. The higher number of patients, the increasing prevalence of genetic disorders, and government actions to promote genomic research contribute to the region’s market growth. In addition, the rising awareness and acquisition of genotyping technologies, coupled with the rising number of collaborations between academic institutes and industry players, are driving the growth of the genotyping market in the Asia Pacific during the forecast period.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global genotyping market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Thermo Fisher Scientific Inc.
• Agilent Technologies, Inc.
• Danaher Corporation
• QIAGEN N.V.
• PerkinElmer, Inc.
• Luminex Corporation
• Eurofins Scientific
• Pacific Biosciences of California, Inc
• GENEWIZ Germany GmbH
• Takara Bio Inc.
• F. Hoffmann-La Roche Ltd
• Bio-Rad Laboratories, Inc.
• Fluidigm Corporation
• Qiagen Inc.
• Affymetrix, Inc.
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Developments

• In August 2022, Thermo Fisher Scientific, launched its Applied Biosystems HIV-1 Genotyping Kit, which analyze positive samples of the human immunodeficiency virus (HIV) to identify genetic variants that resist common antiretroviral drugs. This improves the survival of genotyping products for the company.

 

• In February 2021, Novacyt introduces the SNPsig portfolio of PCR genotyping assays. It is helpful in diagnosing SARS-CoV-2 variants.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Genotyping Market based on the below-mentioned segments: 

 

Global Genotyping Market, By Product

• Reagent & Kit
• Instrument
• Software
• Service

 

Global Genotyping Market, By Technology

• PCR
• Sequencing
• Microarray
• Mass Spectroscopy

 

Global Genotyping Market, By Application

• Diagnostics & Personalized Medicine
• Pharmacogenomics
• Animal Genetics

 

Global Genotyping Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa